Aridis Pharmaceuticals' market value is the price at which a share of Aridis Pharmaceuticals trades on a public exchange. It measures the collective expectations of Aridis Pharmaceuticals investors about its performance. Aridis Pharmaceuticals is selling for under 2.0E-4 as of the 6th of February 2026; that is 92.86 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.0E-4. With this module, you can estimate the performance of a buy and hold strategy of Aridis Pharmaceuticals and determine expected loss or profit from investing in Aridis Pharmaceuticals over a given investment horizon. Check out Aridis Pharmaceuticals Correlation, Aridis Pharmaceuticals Volatility and Aridis Pharmaceuticals Performance module to complement your research on Aridis Pharmaceuticals.
Understanding that Aridis Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aridis Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aridis Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Aridis Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aridis Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aridis Pharmaceuticals.
0.00
11/08/2025
No Change 0.00
0.0
In 3 months and 1 day
02/06/2026
0.00
If you would invest 0.00 in Aridis Pharmaceuticals on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Aridis Pharmaceuticals or generate 0.0% return on investment in Aridis Pharmaceuticals over 90 days. Aridis Pharmaceuticals is related to or competes with HST Global. Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of target... More
Aridis Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aridis Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aridis Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aridis Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aridis Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Aridis Pharmaceuticals historical prices to predict the future Aridis Pharmaceuticals' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aridis Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aridis Pharmaceuticals is out of control given 3 months investment horizon. Aridis Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.35, which signifies that the company had a 0.35 % return per unit of risk over the last 3 months. We were able to break down twenty-six different technical indicators, which can help you to evaluate if expected returns of 115.51% are justified by taking the suggested risk. Use Aridis Pharmaceuticals Downside Deviation of 89.96, risk adjusted performance of 0.2795, and Mean Deviation of 239.06 to evaluate company specific risk that cannot be diversified away. Aridis Pharmaceuticals holds a performance score of 27 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -56.61, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Aridis Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Aridis Pharmaceuticals is expected to outperform it. Use Aridis Pharmaceuticals total risk alpha and the relationship between the potential upside and period momentum indicator , to analyze future returns on Aridis Pharmaceuticals.
Auto-correlation
0.15
Insignificant predictability
Aridis Pharmaceuticals has insignificant predictability. Overlapping area represents the amount of predictability between Aridis Pharmaceuticals time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aridis Pharmaceuticals price movement. The serial correlation of 0.15 indicates that less than 15.0% of current Aridis Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
0.15
Spearman Rank Test
0.47
Residual Average
0.0
Price Variance
0.0
Thematic Opportunities
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
When running Aridis Pharmaceuticals' price analysis, check to measure Aridis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aridis Pharmaceuticals is operating at the current time. Most of Aridis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aridis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aridis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aridis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.